4.13 -0.02(-0.36%)09/18/2024
PermRock Royalty Trust (PRT)
PermRock Royalty Trust (PRT)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Prelude Therapeutics' SMARCA2 Degrader PRT3789 Demonstrated Promising Initial Clinical Activity and Safety Profile in Phase 1 Trial | 09/13 10:00 | globenewswire.com |
| PermRock Royalty Trust Declares Monthly Cash Distribution | 08/20 06:30 | prnewswire.com |
| Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers | 07/09 07:30 | globenewswire.com |